Laboratorios Farma | ROVI - Pre Tax Profit

Stock Price
58.55
Daily Change
-0.05 -0.09%
Monthly
-31.56%
Yearly
11.00%
Q2 Forecast
57.41

Laboratorios Farma reported EUR26.78M in Pre-Tax Profit for its fiscal semester ending in June of 2025.





Pre Tax Profit Change Date
Akebia Therapeutics USD -11.24M 12.39M Dec/2025
Alaunos Therapeutics USD -7.84M 633K Dec/2023
Almirall EUR 30.32M 22M Dec/2025
Avita Medical AUD -11.64M 12.13M Dec/2025
Dianthus Therapeutics USD -64.43M 27.67M Dec/2025
Ionis Pharmaceuticals USD -93M 135M Mar/2026
IQVIA Holdings USD 6.22B 5.68B Mar/2026
Laboratorios Farma EUR 26.78M 94.77M Jun/2025
Moderna USD -799M 612M Dec/2025
Organon & Co USD -148M 391M Dec/2025
Pharma Mar EUR 1.6M 38.6M Mar/2026
Revvity USD 91.56M 35.88M Dec/2025
Tectonic Therapeutic USD -18.97M 63K Dec/2025
Viatris USD -343M 335.1M Dec/2025
Xeris Pharmaceuticals USD 11.08M 10.46M Dec/2025